Document:

Exhibit 4.3

 

180 LIFE SCIENCES CORP.

 

2022 OMNIBUS INCENTIVE PLAN 

 

NOTICE OF RESTRICTED STOCK GRANT

 

Capitalized but otherwise
undefined terms in this Notice of Restricted Stock Grant and the attached Restricted Stock Grant Agreement shall have the same defined
meanings as in the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (as amended from time to time) (the “Plan”).

 

Grantee Name:
________________________________

 

Address: ________________________________

 

You have been granted shares
of restricted Common Stock (the “Restricted Stock” or the “Shares”) subject
to the terms and conditions of the Plan and the attached Restricted Stock Grant Agreement, as follows:

 

Date of Grant: ______________

 

Vesting Commencement Date: ______________

 

Price Per Share: ______________

 

Total Number of Shares Granted: ______________

 

Total Value of Shares Granted: ______________

 

Total Purchase Price: $__, Issued In Consideration
For Services

 

Agreement Date: _________________________

 

Vesting Schedule: ______________________________________.

 

    Page 1 of 10
180 Life Sciences Corp.
2022 Omnibus Incentive Plan
Restricted Stock Grant Agreement

    	

    

 

180 LIFE SCIENCES CORP.

 

2022 OMNIBUS INCENTIVE PLAN 

 

RESTRICTED STOCK GRANT AGREEMENT

 

This RESTRICTED STOCK
GRANT AGREEMENT (“Agreement”), dated as of the Agreement Date specified on the Notice of Restricted
Stock Grant is made by and between 180 Life Sciences Corp., a Delaware corporation (the “Company”), and the
grantee named in the Notice of Restricted Stock Grant (the “Grantee,” which term as used herein
shall be deemed to include any successor to Grantee by will or by the laws of descent and distribution, unless the context shall otherwise
require).

 

BACKGROUND

 

Pursuant to the Plan, the
Board (or an authorized Committee thereof), approved the issuance to Grantee, effective as of the date set forth above, of an award of
the number of shares of Restricted Stock as is set forth in the attached Notice of Restricted Stock Grant (which is expressly incorporated
herein and made a part hereof, the “Notice of Restricted Stock Grant”) at the purchase price per share
of Restricted Stock (the “Purchase Price”), if any, set forth in the attached Notice of Restricted Stock Grant,
upon the terms and conditions hereinafter set forth.

 

NOW, THEREFORE, in
consideration of the mutual premises and undertakings hereinafter set forth, the parties agree as follows:

 

1.   Grant
and Purchase of Restricted Stock. The Company hereby grants to Grantee, and Grantee hereby accepts the Restricted Stock set forth
in the Notice of Restricted Stock Grant, subject to the payment by Grantee of the total purchase price, if any, set forth in the Notice
of Restricted Stock Grant.

 

2.   Stockholder
Rights.

 

(a)   Voting
Rights. Until such time as all or any part of the Restricted Stock are forfeited to the Company under this Agreement, if ever, Grantee
(or any successor in interest) has the rights of a stockholder, including voting rights, with respect to the Restricted Stock subject,
however, to the transfer restrictions or any other restrictions set forth in the Plan.

 

(b)   Dividends
and Other Distributions. During the period of restriction, Participants holding Restricted Stock are entitled to all regular cash
dividends or other distributions paid with respect to all shares while they are so held. If any such dividends or distributions are paid
in shares, such shares will be subject to the same restrictions on transferability and forfeitability as the Restricted Stock with respect
to which they were paid.

 

    Page 2 of 10
180 Life Sciences Corp.
2022 Omnibus Incentive Plan
Restricted Stock Grant Agreement

    	

    

 

3.   Vesting
of Restricted Stock.

 

(a)   The
Restricted Stock are restricted and subject to forfeiture until vested. The Restricted Stock which have vested and are no longer subject
to forfeiture are referred to as “Vested Shares.” All Restricted Stock which have not become Vested Shares are
referred to as “Nonvested Shares.”

 

(b)   Restricted
Stock will vest and become nonforfeitable in accordance with the vesting schedule contained in the Notice of Restricted Stock Grant.

 

(c)   Any
Nonvested Shares will automatically vest and become nonforfeitable if Grantee’s service with the Company ceases owing to the Grantee’s
(a) death; or (b) Retirement.

 

(d)   Any
Nonvested Shares will vest and become nonforfeitable immediately prior to the date of a Change of Control, provided that the Board (or
an authorized committee thereof), in its discretion, may also accelerate the time at which all or any portion of Grantee’s Nonvested
Shares will vest prior to a contemplated Change of Control.

 

(e)   Terms
used in Section 3 and Section 4 have the following meanings:

 

(i)   “Cause”
has the meaning ascribed to such term or words of similar import in Grantee’s written employment or service contract with the Company
or its subsidiaries and, in the absence of such agreement or definition, means Grantee’s (i) conviction of, or plea of nolo
contendere to, a felony or crime involving moral turpitude; (ii) fraud on or misappropriation of any funds or property of the
Company or its subsidiaries, or any affiliate, customer or vendor; (iii) personal dishonesty, incompetence, willful misconduct, willful
violation of any law, rule or regulation (other than minor traffic violations or similar offenses), or breach of fiduciary duty which
involves personal profit; (iv) willful misconduct in connection with Grantee’s duties or willful failure to perform Grantee’s
responsibilities in the best interests of the Company or its subsidiaries; (v) illegal use or distribution of drugs; (vi) violation
of any material rule, regulation, procedure or policy of the Company or its subsidiaries, the violation of which could have a material
detriment to the Company; or (vii) material breach of any provision of any employment, non-disclosure, non-competition, non-solicitation
or other similar agreement executed by Grantee for the benefit of the Company or its subsidiaries, all as reasonably determined by the
Board of Directors of the Company, which determination will be conclusive.

 

    Page 3 of 10
180 Life Sciences Corp.
2022 Omnibus Incentive Plan
Restricted Stock Grant Agreement

    	

    

 

(ii)   “Retirement”
means Grantee’s retirement from Company employ at or above the age 65 as determined in accordance with the policies of the Company
or its subsidiaries, if any, in good faith by the Board of Directors of the Company, which determination will be final and binding on
all parties concerned.

 

(f)   Nonvested
Shares may not be sold, transferred, assigned, pledged, or otherwise disposed of, directly or indirectly, whether by operation of law
or otherwise. The restrictions set forth in this Section will terminate upon a Change of Control.

 

4.   Forfeiture
of Nonvested Shares. Except as provided herein, if Grantee’s service with the Company ceases for any reason (including Disability)
other than Grantee’s (a) Retirement or (b) death, any Nonvested Shares will be automatically forfeited to the Company for no consideration;
unless the Board (or an authorized committee thereof) provides otherwise, and provided, however, that the Board (or an authorized committee
thereof) may cause any Nonvested Shares immediately to vest and become nonforfeitable if Grantee’s service with the Company is terminated
by the Company without Cause.

 

(a)   Legend.
Each certificate representing Restricted Stock granted pursuant to the Notice of Restricted Stock Grant may bear a legend substantially
as follows:

 

“THE SALE OR OTHER TRANSFER OF THE SHARES
REPRESENTED BY THIS CERTIFICATE, WHETHER VOLUNTARY, INVOLUNTARY OR BY OPERATION OF LAW, IS SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER
AS SET FORTH IN THE 180 LIFE SCIENCES CORP. 2022 OMNIBUS INCENTIVE PLAN AND IN A RESTRICTED SHARE GRANT AGREEMENT. A COPY OF SUCH PLAN
AND SUCH AGREEMENT MAY BE OBTAINED FROM 180 LIFE SCIENCES CORP.”

 

(b)   Escrow
of Nonvested Shares. The Company has the right to retain the certificates representing Nonvested Shares in the Company’s possession
until such time as all restrictions applicable to such shares have been satisfied.

 

(c)   Removal
of Restrictions. The Participant is entitled to have the legend removed from certificates representing Vested Shares.

 

5.   Recapitalizations,
Exchanges, Mergers, Etc. The provisions of this Agreement apply to the full extent set forth herein with respect to any and all
shares of capital stock of the Company or successor of the Company which may be issued in respect of, in exchange for, or in substitution
for the Restricted Stock by reason of any stock dividend, split, reverse split, combination, recapitalization, reclassification, merger,
consolidation or otherwise which does not terminate this Agreement. Except as otherwise provided herein, this Agreement is not intended
to confer upon any other person except the parties hereto any rights or remedies hereunder.

 

    Page 4 of 10
180 Life Sciences Corp.
2022 Omnibus Incentive Plan
Restricted Stock Grant Agreement

    	

    

 

6.   Grantee
Representations.

 

Grantee represents to the
Company the following:

 

(a)   Restrictions
on Transfer. Grantee acknowledges that the Restricted Stock to be issued to Grantee must be held indefinitely unless subsequently
registered and qualified under the Securities Act of 1933, as amended (the “Securities Act”) or unless
an exemption from registration and qualification is otherwise available. In addition, Grantee understands that the certificate representing
the Restricted Stock will be imprinted with a legend which prohibits the transfer of such Restricted Stock unless they are sold in a transaction
in compliance with the Securities Act or are registered and qualified or such registration and qualification are not required in the opinion
of counsel acceptable to the Company.

 

(b)   Relationship
to the Company; Experience. Grantee either has a preexisting business or personal relationship with the Company or any of its officers,
directors or controlling persons or, by reason of Grantee’s business or financial experience or the business or financial experience
of Grantee’s personal representative(s), if any, who are unaffiliated with and who are not compensated by the Company or any affiliate
or selling agent, directly or indirectly, has the capacity to protect Grantee’s own interests in connection with Grantee’s
acquisition of the Restricted Stock to be issued to Grantee hereunder. Grantee and/or Grantee’s personal representative(s) have
such knowledge and experience in financial, tax and business matters to enable Grantee and/or them to utilize the information made available
to Grantee and/or them in connection with the acquisition of the Restricted Stock to evaluate the merits and risks of the prospective
investment and to make an informed investment decision with respect thereto.

 

(c)   Grantee’s
Liquidity. In reaching the decision to invest in the Restricted Stock, Grantee has carefully evaluated Grantee’s financial resources
and investment position and the risks associated with this investment, and Grantee acknowledges that Grantee is able to bear the economic
risks of the investment. Grantee (i) has adequate means of providing for Grantee’s current needs and possible personal contingencies,
(ii) has no need for liquidity in Grantee’s investment, (iii) is able to bear the substantial economic risks of an investment
in the Restricted Stock for an indefinite period and (iv) at the present time, can afford a complete loss of such investment. Grantee’s
commitment to investments which are not readily marketable is not disproportionate to Grantee’s net worth and Grantee’s investment
in the Restricted Stock will not cause Grantee’s overall commitment to become excessive.

 

(d)   Access
to Data. Grantee acknowledges that during the course of this transaction and before deciding to acquire the Restricted Stock, Grantee
has been provided with financial and other written information about the Company. Grantee has been given the opportunity by the Company
to obtain any information and ask questions concerning the Company, the Restricted Stock, and Grantee’s investment that Grantee
felt necessary; and to the extent Grantee availed himself/herself of that opportunity, Grantee has received satisfactory information and
answers concerning the business and financial condition of the Company in response to all inquiries in respect thereof.

 

    Page 5 of 10
180 Life Sciences Corp.
2022 Omnibus Incentive Plan
Restricted Stock Grant Agreement

    	

    

 

(e)   Risks.
Grantee acknowledges and understands that (i) an investment in the Company constitutes a high risk, (ii) the Restricted Stock
are highly speculative, and (iii) there can be no assurance as to what investment return, if any, there may be. Grantee is aware
that the Company may issue additional securities in the future which could result in the dilution of Grantee’s ownership interest
in the Company.

 

(f)   Valid
Agreement. This Agreement when executed and delivered by Grantee will constitute a valid and legally binding obligation of Grantee
which is enforceable in accordance with its terms.

 

(g)   Residence.
The address set forth on the Notice of Restricted Stock Grant is Grantee’s current address and accurately sets forth Grantee’s
place of residence.

 

(h)   Tax
Consequences. Grantee has reviewed with Grantee’s own tax advisors the federal, state, local and foreign tax consequences of
this investment and the transactions contemplated by this Agreement. Grantee is relying solely on such advisors and not on any statements
or representations of the Company or any of its agents. Grantee understands that Grantee (and not the Company) is responsible for
Grantee’s own tax liability that may arise as a result of the transactions contemplated by this Agreement. Grantee understands that
Section 83 of the Internal Revenue Code of 1986, as amended (the “Code”), taxes as ordinary income the
difference between the purchase price for the Restricted Stock and the fair market value of the Restricted Stock as of the date any restrictions
on the Restricted Stock lapse. Grantee understands that Grantee may elect to be taxed at the time the Restricted Stock is purchased rather
than when and as the restrictions lapse by filing an election under Section 83(b) of the Code with the Internal Revenue Service
within 30 days from the date of purchase. The form for making this election is attached as Exhibit A hereto.

 

GRANTEE ACKNOWLEDGES THAT IT IS GRANTEE’S
SOLE RESPONSIBILITY AND NOT THE COMPANY’S TO FILE TIMELY ANY ELECTION UNDER SECTION 83(b), EVEN IF GRANTEE REQUESTS THE COMPANY
OR ITS REPRESENTATIVES TO MAKE THIS FILING ON GRANTEE’S BEHALF.

 

7.   No
Employment Contract Created. The issuance of the Restricted Stock is not to be construed as granting to Grantee any right with
respect to continuance of employment or any service with the Company or any of its subsidiaries. The right of the Company or any of its
subsidiaries to terminate at will Grantee’s employment or terminate Grantee’s service at any time (whether by dismissal, discharge
or otherwise), with or without cause, is specifically reserved, subject to any other written employment or other agreement to which the
Company and Grantee may be a party.

 

    Page 6 of 10
180 Life Sciences Corp.
2022 Omnibus Incentive Plan
Restricted Stock Grant Agreement

    	

    

 

8.   Tax
Withholding. The Company has the power and the right to deduct or withhold, or require Grantee to remit to the Company, an amount
sufficient to satisfy Federal, state and local taxes (including the Grantee’s FICA obligation) required by law to be withheld
with respect to the grant and vesting of the Restricted Stock.

 

9.   Interpretation.
The Restricted Stock are being issued pursuant to the terms of the Plan, and are to be interpreted in accordance therewith. The Board
(or an authorized committee thereof) will interpret and construe this Agreement and the Plan, and any action, decision, interpretation
or determination made in good faith by the Board (or an authorized committee thereof) will be final and binding on the Company and
Grantee.

 

10.   Notices.
All notices or other communications which are required or permitted hereunder will be in writing and sufficient if (i) personally
delivered or sent by telecopy, (ii) sent by nationally-recognized overnight courier or (iii) sent by registered or certified
mail, postage prepaid, return receipt requested, addressed as follows:

 

(a)   if
to the Grantee, to the address (or telecopy number) set forth on the Notice of Grant; and

 

(b)   if
to the Company, to its principal executive office as specified in any report filed by the Company with the Securities and Exchange Commission
or to such address as the Company may have specified to the Grantee in writing, Attention: Corporate Secretary;

 

or to such other address as
the party to whom notice is to be given may have furnished to the other party in writing in accordance herewith. Any such communication
will be deemed to have been given (i) when delivered, if personally delivered, or when telecopied, if telecopied, (ii) on the
first Business Day (as hereinafter defined) after dispatch, if sent by nationally-recognized overnight courier and (iii) on
the fifth Business Day following the date on which the piece of mail containing such communication is posted, if sent by mail. As used
herein, “Business Day” means a day that is not a Saturday, Sunday or a day on which banking institutions in
the city to which the notice or communication is to be sent are not required to be open.

 

11.   Specific
Performance. Grantee expressly agrees that the Company will be irreparably damaged if the provisions of this Agreement and the
Plan are not specifically enforced. Upon a breach or threatened breach of the terms, covenants and/or conditions of this Agreement or
the Plan by Grantee, the Company will, in addition to all other remedies, be entitled to a temporary or permanent injunction, without
showing any actual damage, and/or decree for specific performance, in accordance with the provisions hereof and thereof. The Board (or
an authorized committee thereof) has the power to determine what constitutes a breach or threatened breach of this Agreement or the
Plan. Any such determinations will be final and conclusive and binding upon Grantee.

 

    Page 7 of 10
180 Life Sciences Corp.
2022 Omnibus Incentive Plan
Restricted Stock Grant Agreement

    	

    

 

12.   No
Waiver. No waiver of any breach or condition of this Agreement will be deemed to be a waiver of any other or subsequent breach
or condition, whether of like or different nature.

 

13.   Grantee
Undertaking. Grantee hereby agrees to take whatever additional actions and execute whatever additional documents the Company may
in its reasonable judgment deem necessary or advisable in order to carry out or effect one or more of the obligations or restrictions
imposed on Grantee pursuant to the express provisions of this Agreement.

 

14.   Modification
of Rights. The rights of Grantee are subject to modification and termination in certain events as provided in this Agreement and
the Plan.

 

15.   Governing
Law. This Agreement is governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect
to its conflict or choice of law principles that might otherwise refer construction or interpretation of this Agreement to the substantive
law of another jurisdiction.

 

16.   Counterparts;
Facsimile Execution. This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original,
but all of which together will constitute one and the same instrument. Facsimile execution and delivery of this Agreement is legal,
valid and binding execution and delivery for all purposes.

 

17.   Entire
Agreement. This Agreement (including the Notice of Restricted Stock Grant) and the Plan, constitute the entire agreement
between the parties with respect to the subject matter hereof, and supersedes all previously written or oral negotiations, commitments,
representations and agreements with respect thereto.

 

18.   Severability.
In the event one or more of the provisions of this Agreement should, for any reason, be held to be invalid, illegal or unenforceable in
any respect, such invalidity, illegality or unenforceability will not affect any other provisions of this Agreement, and this Agreement
will be construed as if such invalid, illegal or unenforceable provision had never been contained herein.

 

19.   No
Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations
regarding your participation in the Plan, or your acquisition or sale of the Restricted Stock. You should consult with your own personal
tax, legal and financial advisors regarding your participation in the Plan before taking any action related to the Plan.

 

20.   Compliance
With Law. You agree that the Company shall have unilateral authority to amend this Agreement without your consent to the extent
necessary to comply with securities or other laws applicable to issuance of shares of Restricted Stock.

 

21.   Electronic
Delivery and Participation. The Company may, in its sole discretion, decide to deliver any documents related to current or future
participation in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate
in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company.

 

22.   Other
Documents. To the extent the Plan is registered under the Securities Act, you hereby acknowledge receipt of or the right to receive
a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Prospectus.

 

23.   WAIVER
OF JURY TRIAL. THE GRANTEE HEREBY EXPRESSLY, IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING
RELATING TO THIS AGREEMENT AND FOR ANY COUNTERCLAIM THEREIN.

 

[Signature Page Follows]

 

    Page 8 of 10
180 Life Sciences Corp.
2022 Omnibus Incentive Plan
Restricted Stock Grant Agreement

    	

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Restricted Share Grant Agreement as of the date first written above.

 

180 LIFE SCIENCES CORP.

 

By: __________________________________________

 

Name:________________________________________

 

Title:
_________________________________________

 

GRANTEE:

 

Name:
________________________________________

 

    Page 9 of 10
180 Life Sciences Corp.
2022 Omnibus Incentive Plan
Restricted Stock Grant Agreement

    	

    

 

 

SPOUSE’S CONSENT TO AGREEMENT

(Required where Grantee resides in a community
property state)

 

I acknowledge that I have
read the Agreement and the Plan and that I know and understand the contents of both. I am aware that my spouse has agreed therein to the
imposition of certain forfeiture provisions and restrictions on transferability with respect to the Restricted Stock that are the subject
of the Agreement, including with respect to my community interest therein, if any, on the occurrence of certain events described in the
Agreement. I hereby consent to and approve of the provisions of the Agreement, and agree that I will abide by the Agreement and bequeath
any interest in the Restricted Stock which represents a community interest of mine to my spouse or to a trust subject to my spouse’s control
or for my spouse’s benefit or the benefit of our children if I predecease my spouse.

 

Dated: ________________________________

 

Signature: _____________________________

 

Print Name: ____________________________

 

    Page 10 of 10
180 Life Sciences Corp.
2022 Omnibus Incentive Plan
Restricted Stock Grant Agreement

    	

    

 

ELECTION UNDER SECTION 83(b)

OF THE INTERNAL REVENUE CODE OF 1986

 

The undersigned taxpayer hereby
elects, pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in the taxpayer’s gross income
or alternative minimum taxable income, as the case may be, for the current taxable year, as compensation for services the excess (if any) of
the fair market value of the shares described below over the amount paid for those shares:

 

1.   The
name, address, taxpayer identification number and taxable year of the undersigned are as follows:

 

	Taxpayer:	 	 
	Spouse:	 	 
	Name:	 	 
	Address:	 	 
	Identification No.:	 	 
	Taxable Year:	 	 

 

2.   The
property with respect to which the election is made is described as follows: __________ shares (the “Shares”) of
the Common Stock of 180 Life Sciences Corp., a Delaware corporation (the “Company”).

 

3.   The
date on which the property was transferred is:___________________ ,______.

 

4.   The
property is subject to the following restrictions: The Shares may not be transferred and are subject to forfeiture under the terms of
an agreement between the taxpayer and the Company. These restrictions lapse upon the satisfaction of certain conditions contained in such
agreement.

 

5.   The
fair market value of the property at the time of transfer (determined without regard to any restriction other than a nonlapse restriction
as defined in § 1.83-3(h) of the Income Tax Regulations) is: $_______ per share x ________ shares = $___________.

 

6.   For
the property transferred, the undersigned paid $______ per share x _________ shares = $______________.

 

7.   The
amount to include in gross income is $______________. [The result of the amount reported in Item 5 minus the amount reported in
Item 6.]

 

The undersigned taxpayer will file this election
with the Internal Revenue Service office with which taxpayer files his or her annual income tax return not later than 30 days after the
date of transfer of the property. A copy of the election also will be furnished to the person for whom the services were performed. Additionally,
the undersigned will include a copy of the election with his or her income tax return for the taxable year in which the property is transferred.
The undersigned is the person performing the services in connection with which the property was transferred.

 

The undersigned understands that the foregoing
election may not be revoked except with the consent of the Commissioner.

 

Dated: ______________________, _____

 

___________________________

Taxpayer

 

The undersigned spouse of taxpayer joins in this
election.

 

Dated: ______________________, _____

 

_________________________

Spouse of TaxpayerExhibit 10.1

 

		 	

	 	 	 

 

 

INSEEGO CORP.

2018 Omnibus Incentive Compensation Plan

 

 1. Purpose. Inseego Corp. hereby amends and restates the Inseego Corp. 2009 Omnibus Incentive Compensation Plan into this Inseego Corp. 2018 Omnibus Incentive Compensation Plan. The purpose of the Plan is to promote the long-term success of the Company and the creation of stockholder value by offering directors, officers, employees and consultants of the Company an opportunity to acquire a proprietary interest in the success of the Company, or to increase such interest, and to encourage such selected persons to continue to provide services to the Company and to attract new individuals with outstanding qualifications.

 

2. Definitions.
As used in the Plan,

 

(a) “Affiliate”
means any entity other than a Subsidiary, if the Company and/or one or more Subsidiaries owns not less than 50 percent of such entity.

 

(b) “Aggregate
Share Limit” means the aggregate maximum number of shares available under the Plan pursuant to Section 3(a)(i) of the Plan.

 

(c) “Annual
Incentive Award” means a cash award granted pursuant to Section 8 of the Plan, where such award is based on Management Objectives
and a Performance Period of one year or less.

 

(d) “Appreciation
Right” means a right granted pursuant to Section 5 of the Plan.

 

(e) “Award”
means any Annual Incentive Award, Option Right, Restricted Stock, Restricted Stock Unit, Appreciation Right, Performance Share, Performance
Unit or Other Award granted pursuant to the terms of the Plan.

 

(f) “Base
Price” means the price to be used as the basis for determining the Spread upon the exercise of an Appreciation Right.

 

(g) “Beneficial
Owner” or “Beneficial Ownership” has the meaning ascribed to such term in Rule 13d-3 of the General Rules and Regulations
under the Exchange Act.

 

(h) “Board”
means the Board of Directors of Inseego, as constituted from time to time.

 

(i) “Change
in Control” means, except as may otherwise be provided in an Evidence of Award or in a Participant’s written employment agreement,
change-in-control agreement, severance agreement, or other similar written agreement or arrangement that expressly provides that such
definition applies with respect to this Plan, the first to occur of the following events:

 

(i) any
Person is or becomes the Beneficial Owner of 50 percent or more of the combined voting power of the then-outstanding Voting Stock of
Inseego; provided, however, that:

 

(1) the
following acquisitions will not constitute a Change in Control: (A) any acquisition of Voting Stock of Inseego directly from Inseego
that is approved by a majority of the Incumbent Directors, (B) any acquisition of Voting Stock of Inseego by the Company, (C) any acquisition
of Voting Stock of Inseego by the trustee or other fiduciary holding securities under any employee benefit plan (or related trust) sponsored
or maintained by the Company, and (D) any acquisition of Voting Stock of Inseego by any Person pursuant to a Business Transaction (as
defined below) that complies with clauses (A), (B) and (C) of Section 2(i)(iii) below;

 

 

    	 	1	 

     

    

 

		 	

	 	 	 

 

 

(2) if any
Person is or becomes the Beneficial Owner of 50 percent or more of the combined voting power of the then-outstanding Voting Stock of
Inseego as a result of a transaction described in clause (A) of Section 2(i)(i)(1) above and such Person thereafter becomes the Beneficial
Owner of any additional shares of Voting Stock of Inseego representing one percent or more of the then-outstanding Voting Stock of Inseego,
other than in an acquisition directly from Inseego that is approved by a majority of the Incumbent Directors or other than as a result
of a stock dividend, stock split or similar transaction effected by Inseego in which all holders of Voting Stock are treated equally,
such subsequent acquisition will be treated as a Change in Control;

 

(3) a Change
in Control will not be deemed to have occurred if a Person is or becomes the Beneficial Owner of 50 percent or more of the Voting Stock
of Inseego as a result of a reduction in the number of shares of Voting Stock of Inseego outstanding pursuant to a transaction or series
of transactions that is approved by a majority of the Incumbent Directors unless and until such Person thereafter becomes the Beneficial
Owner of any additional shares of Voting Stock of Inseego representing one percent or more of the then-outstanding Voting Stock of Inseego,
other than as a result of a stock dividend, stock split or similar transaction effected by Inseego in which all holders of Voting Stock
are treated equally; and

 

(4) if at
least a majority of the Incumbent Directors determine in good faith that a Person has acquired Beneficial Ownership of 50 percent or
more of the Voting Stock of Inseego inadvertently, and such Person divests as promptly as practicable but no later than the date, if
any, set by the Incumbent Directors a sufficient number of shares so that such Person has Beneficial Ownership of less than 50 percent
of the Voting Stock of Inseego, then no Change in Control will have occurred as a result of such Person’s acquisition; or

 

(ii) a majority
of the Board ceases to be comprised of Incumbent Directors; or

 

(iii) the
consummation of a reorganization, merger or consolidation, or sale or other disposition of all or substantially all of the assets of
Inseego or the acquisition of the stock or assets of another corporation, or other transaction (each, a “Business Transaction”),
unless, in each case, immediately following such Business Transaction (A) the Voting Stock of Inseego outstanding immediately prior to
such Business Transaction continues to represent (either by remaining outstanding or by being converted into Voting Stock of the surviving
entity or any parent thereof), more than 50 percent of the combined voting power of the then outstanding shares of Voting Stock of the
entity resulting from such Business Transaction (including, without limitation, an entity which as a result of such transaction owns
Inseego or all or substantially all of Inseego’s assets either directly or through one or more subsidiaries) in substantially the
same proportions relative to each other as their ownership, immediately prior to such Business Transaction, of the Voting Stock of Inseego,
(B) no Person (other than Inseego, such entity resulting from such Business Transaction, or any employee benefit plan (or related trust)
sponsored or maintained by the Company or such entity resulting from such Business Transaction) has Beneficial Ownership, directly or
indirectly, of 50 percent or more of the combined voting power of the then outstanding shares of Voting Stock of the entity resulting
from such Business Transaction, and (C) at least a majority of the members of the Board of Directors of the entity resulting from such
Business Transaction were Incumbent Directors at the time of the execution of the initial agreement or of the action of the Board providing
for such Business Transaction; or

 

(iv) Inseego
implements a plan for liquidation or dissolution of Inseego, except pursuant to a Business Transaction that complies with clauses (A),
(B) and (C) of Section 2(i)(iii).

 

(j) “Code”
means the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, as such law and regulations may be amended
from time to time.

 

 

    	 	2	 

     

    

 

		 	

	 	 	 

 

 

(k) “Committee”
means a committee consisting of one or more members of the Board that is appointed by the Board (as described in Section 12) to administer
the Plan.

 

(l) “Company”
means, collectively, Inseego and its Subsidiaries.

 

(m) “Consultant”
means an individual who performs bona fide services to the Company or an Affiliate, other than as an Employee or Director.

 

(n) “Date
of Grant” means the date specified by the Board on which a grant of an Award will become effective (which date will not be earlier
than the date on which the Board takes action with respect thereto).

 

(o) “Director”
means a member of the Board of Directors of Inseego.

 

(p) “Employee”
means an individual who is an employee of the Company or an Affiliate.

 

(q) “Evidence
of Award” means an agreement, certificate, resolution, notification or other type or form of writing or other evidence approved
by the Board that sets forth the terms and conditions of the Awards granted. An Evidence of Award may be in an electronic medium, may
be limited to notation on the books and records of Inseego and, unless otherwise determined by the Board, need not be signed by a representative
of Inseego or a Participant.

 

(r) “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, as such law, rules and regulations
may be amended from time to time.

 

(s) “GAAP”
means accounting principles generally accepted in the United States of America as in effect from time to time.

 

(t) “Incentive
Stock Options” means Option Rights that are intended to qualify as “incentive stock options” under Section 422 of the
Code or any successor provision.

 

(u) “Incumbent
Directors” means the individuals who, as of the date this amended and restated plan was adopted by the Board, are Directors of
Inseego and any individual becoming a Director subsequent to the date hereof whose election, nomination for election by Inseego’s
stockholders, or appointment, was approved by a vote of at least two-thirds of the then Incumbent Directors (either by a specific vote
or by approval of the proxy statement of Inseego in which such person is named as a nominee for Director, without objection to such nomination);
provided, however, that an individual will not be an Incumbent Director if such individual’s election or appointment to the Board
occurs as a result of an actual or threatened election contest with respect to the election or removal of Directors or other actual or
threatened solicitation of proxies or consents by or on behalf of a Person other than the Board.

 

(v) “Inseego”
means Inseego Corp., a Delaware corporation, and any successors thereto.

 

(w) “Investor
Director Provider” means any investor in the Company (or the Affiliate of an investor in the Company) that has an employee, direct
or indirect owner, or service provider of such investor serving on the Board as a Director, provided that such Director has agreed with
the investor (or Affiliate) that such investor (or Affiliate of such investor) will receive any Awards that such Director otherwise would
receive.

 

(x) “Management
Objectives” means the performance objective or objectives established pursuant to the Plan for Participants who have received grants
of Annual Incentive Awards, Performance Shares or Performance Units or, when so determined by the Board, Option Rights, Appreciation
Rights, Restricted Stock, Restricted Stock Units, dividend equivalents or Other Awards pursuant to the Plan. Management Objectives may
be described in terms of Inseego-wide objectives or objectives that are related to the performance of the individual Participant or a
Subsidiary, division, business unit, region or function within Inseego or any Subsidiary. The Management Objectives may be made relative
to the performance of other companies. The Management Objectives may be based on any criteria selected by the Board.

 

 

    	 	3	 

     

    

 

		 	

	 	 	 

 

 

At the Board’s
discretion, any Management Objective may be measured before special items, and may or may not be determined in accordance with GAAP.
The Board shall have the authority to make equitable adjustments to the Management Objectives (and to the related minimum, target and
maximum levels of achievement or performance) as follows: in recognition of unusual or non-recurring events affecting Inseego or any
Subsidiary or Affiliate or the financial statements of Inseego or any Subsidiary or Affiliate; in response to changes in applicable laws
or regulations; to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence
or related to the disposal of a segment of a business or related to a change in accounting principles; or in recognition of any events
or circumstances (including, without limitation, changes in the business, operations, corporate or capital structure of the Company or
the manner in which it conducts its business) that render the Management Objectives unsuitable, as determined by the Board in its sole
discretion.

 

(y) “Market
Value Per Share” means as of any particular date the closing sale price of a Share as reported on the Nasdaq Stock Market or, if
not listed on such exchange, on any other national securities exchange on which the Shares are listed. If the Shares are not traded as
of any given date, the Market Value Per Share means the closing price for the Shares on the principal exchange on which the Shares are
traded for the immediately preceding date on which the Shares were traded. If there is no regular public trading market for the Shares,
the Market Value Per Share of the Shares shall be the fair market value of the Shares as determined in good faith by the Board. The Board
is authorized to adopt another fair market value pricing method, provided such method is in compliance with the fair market value pricing
rules set forth in Section 409A of the Code.

 

(z) “Option
Price” means the purchase price payable on exercise of an Option Right.

 

(aa) “Option
Right” means the right to purchase Shares upon exercise of an option granted pursuant to Section 4 of the Plan.

 

(bb) “Optionee”
means the optionee named in an Evidence of Award evidencing an outstanding Option Right.

 

(cc) “Other
Award” means an Award granted pursuant to Section 9 of the Plan.

 

(dd) “Participant”
means a person who is selected by the Board to receive Awards under the Plan and who is or is expected to become an Employee, Director,
or Consultant, or an Investor Director Provider.

 

(ee) “Performance
Period” means, in respect of an Award, a period of time within which the Management Objectives relating to such Award are to be
achieved, as determined by the Board in its sole discretion. The Board may establish different Performance Periods for different Participants,
and the Board may establish concurrent or overlapping Performance Periods.

 

(ff) “Performance
Share” means an Award under the Plan equivalent to the right to receive one Share awarded pursuant to Section 8 of the Plan.

 

(gg) “Performance
Unit” means a unit awarded pursuant to Section 8 of the Plan that is equivalent to $1.00 or such other value as is determined by
the Board.

 

(hh) “Person”
shall have the meaning set forth in Section 3(a)(9) of the Exchange Act or any successor provision thereto, as modified and used in Sections
13(d) and 14(d) thereof and the rules thereunder.

 

(ii) “Plan”
means this Inseego Corp. 2018 Omnibus Incentive Compensation Plan, as amended.

 

(jj) “Restricted
Stock” means Shares granted pursuant to Section 6 of the Plan as to which neither the substantial risk of forfeiture nor the prohibition
on transfers has expired.

 

 

    	 	4	 

     

    

 

		 	

	 	 	 

 

 

(kk) “Restricted
Stock Unit” means an Award made pursuant to Section 7 of the Plan.

 

(ll) “Restriction
Period” means the period of time during which Restricted Stock or Restricted Stock Units may be subject to restrictions, as provided
in Section 6 and Section 7 of the Plan.

 

(mm) “Secondary
Committee” means one or more senior officers of Inseego (who need not be members of the Board), acting as a committee established
by the Board pursuant to Section 12(b) of the Plan, subject to such conditions and limitations as the Board shall prescribe.

 

(nn) “Shares”
means the shares of common stock, par value $0.001 per share, of Inseego or any security into which such Shares may be changed by reason
of any transaction or event of the type referred to in Section 11 of the Plan.

 

(oo) “Spread”
means the excess of the Market Value Per Share on the date when an Appreciation Right is exercised, or on the date when Option Rights
are surrendered in payment of the Option Price of other Option Rights, over the Option Price or Base Price provided for in the related
Option Right or Appreciation Right, respectively.

 

(pp) “Subsidiary”
means a corporation, company or other entity (i) more than 50 percent of whose outstanding shares or securities (representing the right
to vote for the election of directors or other managing authority) are, or (ii) which does not have outstanding shares or securities
(as may be the case in a partnership, joint venture or unincorporated association), but more than 50 percent of whose ownership interest
representing the right generally to make decisions for such other entity is, now or hereafter, owned or controlled, directly or indirectly,
by Inseego; except that, for purposes of determining whether any person may be a Participant for purposes of any grant of Incentive Stock
Options, “Subsidiary” means any corporation in which at the time Inseego owns or controls, directly or indirectly, more than
50 percent of the total combined voting power represented by all classes of stock issued by such corporation.

 

(qq) “Voting
Stock” means securities entitled to vote generally in the election of directors.

 

(rr) “10%
Shareholder” means a Person who, as of a relevant date, owns or is deemed to own (by reason of the attribution rules applicable
under Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company.

 

3. Shares
Available Under the Plan.

 

(a) Maximum
Shares Available Under Plan.

 

(i) Subject
to adjustment as provided in Section 11 of the Plan, the maximum number of Shares that may be issued (A) upon the exercise of Option
Rights or Appreciation Rights, (B) in payment or settlement of Restricted Stock and released from substantial risks of forfeiture thereof,
(C) in payment or settlement of Restricted Stock Units, (D) in payment or settlement of Performance Shares or Performance Units that
have been earned, (E) in payment or settlement of Other Awards, or (F) in payment of dividend equivalents paid with respect to Awards
made under the Plan, in the aggregate will not exceed 32,753,085 Shares (the “Aggregate Share Limit”).

 

Shares that
are issued in connection with inducement grants pursuant to Nasdaq Listing Rule 5635 and Shares issued under any plan assumed by Inseego
in any corporate transaction will not count against the Aggregate Share Limit.

 

(ii) Shares
covered by an Award granted under the Plan shall not be counted against the Aggregate Share Limit unless and until they are actually
issued and delivered to a Participant and, therefore, the total number of Shares available under the Plan as of a given date shall not
be reduced by any Shares relating to prior Awards that have expired or have been forfeited or cancelled or terminated for any other reason
other than being exercised or settled, and to the extent of payment in cash of the benefit provided by any Award granted under the Plan,
any Shares that were covered by that Award will be available for issue or transfer hereunder. In addition, upon the full or partial payment
of any Option Price by the transfer to the Company of Shares or upon satisfaction of tax withholding provisions in connection with any
such exercise or any other payment made or benefit realized under this Plan by the transfer or relinquishment of Shares, there shall
be deemed to have been issued under this Plan only the net number of Shares actually issued by the Company.

 

 

    	 	5	 

     

    

 

		 	

	 	 	 

 

 

(iii) Subject
to adjustment as provided in Section 11 of the Plan, the aggregate number of Shares actually issued by the Company upon the exercise
of Incentive Stock Options will not exceed 7,000,000 Shares.

 

4. Option
Rights. The Board may, from time to time, authorize the granting to Participants of Option Rights upon such terms and conditions
consistent with the following provisions as it may determine:

 

(a) Each
grant will specify the number of Shares to which it pertains subject to the limitations set forth in Section 3 of the Plan.

 

(b) Each
grant will specify an Option Price per share, which may not be less than (i) the Market Value Per Share on the Date of Grant or (ii)
if the Person to whom an Incentive Stock Option is granted is a 10% Shareholder on the Date of Grant, 110% of the Market Value Per Share
on the Date of Grant. However, an Incentive Stock Option may be granted with an exercise price lower than that set forth in the preceding
sentence if such Incentive Stock Option is granted pursuant to an assumption or substitution for another option in a manner satisfying
the provisions of Section 424 of the Code or if the Award is designated as a “Section 409A Award” and has either a fixed
exercise date or a fixed delivery date.

 

(c) Each
grant will specify whether the Option Price will be payable (i) in cash or by check acceptable to Inseego or by wire transfer of immediately
available funds, (ii) by the actual or constructive transfer to Inseego of Shares owned by the Optionee (or other consideration authorized
pursuant to Section 4(d)) having a value at the time of exercise equal to the total Option Price, (iii) by withholding by Inseego from
the Shares otherwise deliverable to the Optionee upon the exercise of such Option Rights, a number of Shares having a value at the time
of exercise equal to the total Option Price, (iv) by a combination of such methods of payment, or (v) by such other methods as may be
approved by the Board.

 

(d) To the
extent permitted by law, any grant may provide for deferred payment of the Option Price from the proceeds of sale through a bank or broker
on a date satisfactory to Inseego of some or all of the Shares to which such exercise relates.

 

(e) Successive
grants may be made to the same Participant whether or not any Option Rights previously granted to such Participant remain unexercised.

 

(f) Each
grant will specify the period or periods of continuous service by the Optionee with Inseego or any Subsidiary that is necessary before
the Option Rights or installments thereof will become exercisable; provided, however, that in the case of an Investor Director Provider,
service will be deemed continuous as long as such Investor Director Provider has at least one representative on the Board who is an employee,
direct or indirect owner, or service provider of such Investor Director Provider.

 

(g) Any
grant of Option Rights may specify Management Objectives that must be achieved as a condition to the exercise of such rights.

 

(h) Option
Rights granted under the Plan may be (i) Incentive Stock Options, (ii) options that are not intended to qualify as Incentive Stock Options,
or (iii) combinations of the foregoing. Incentive Stock Options may only be granted to Participants who are “employees” (under
Section 3401(c) of the Code) of Inseego or a subsidiary of Inseego (under Section 424 of the Code). Any Option Right designated as an
Incentive Stock Option will not be an Incentive Stock Option to the extent the Option Right fails to meet the requirements of Section
422 of the Code. Each grant will specify whether the Option Right is an Incentive Stock Option or an option that is not intended to qualify
as an Incentive Stock Option.

 

(i) The
Board may substitute, without receiving Participant permission, Appreciation Rights payable only in Shares (or Appreciation Rights payable
in Shares or cash, or a combination of both, at the Board’s discretion) for outstanding Option Rights; provided, however, that
the terms of the substituted Appreciation Rights are substantially the same as the terms for the Option Rights at the date of substitution
and the difference between the Market Value Per Share of the underlying Shares and the Base Price of the Appreciation Rights is equivalent
to the difference between the Market Value Per Share of the underlying Shares and the Option Price of the Option Rights. If the Board
determines, based upon advice from Inseego’s accountants, that this provision creates adverse accounting consequences for Inseego,
it shall be considered null and void.

 

 

    	 	6	 

     

    

 

		 	

	 	 	 

 

 

(j) No Option
Right will be exercisable more than 10 years from the Date of Grant; provided, however, that with respect to Incentive Stock Options
issued to 10% Shareholders, the term of each such Option Right shall not exceed five (5) years from the date it is granted.

 

(k) No grant
of Option Rights may provide for dividends, dividend equivalents or other similar distributions to be paid on such Option Rights.

 

(l) No Option
Right shall include terms entitling the Participant to a grant of Option Rights or Appreciation Rights on exercise of the Option Right.

 

5. Appreciation
Rights. The Board may, from time to time, authorize the granting to any Participant of Appreciation Rights upon such terms and conditions
consistent with the following provisions as it may determine:

 

(a) An Appreciation
Right will be a right of the Participant to receive from Inseego an amount determined by the Board, which will be expressed as a percentage
of the Spread (not exceeding 100 percent) at the time of exercise.

 

(b) Each
grant will specify the Base Price, which may not be less than the Market Value Per Share on the Date of Grant.

 

(c) Any
grant may specify that the amount payable on exercise of an Appreciation Right may be paid by Inseego in cash, in Shares or in any combination
thereof and may retain for the Board the right to elect among those alternatives.

 

(d) Any
grant may specify that the amount payable on exercise of an Appreciation Right may not exceed a maximum specified by the Board at the
Date of Grant.

 

(e) Any
grant may specify waiting periods before exercise and permissible exercise dates or periods.

 

(f) Each
grant will specify the period or periods of continuous service by the Participant with Inseego or any Subsidiary that is necessary before
such Appreciation Right or installments thereof will become exercisable; provided, however, that in the case of an Investor Director
Provider, service will be deemed continuous as long as such Investor Director Provider has at least one representative on the Board who
is an employee, direct or indirect owner, or service provider of such Investor Director Provider.

 

(g) Any
grant of Appreciation Rights may specify Management Objectives that must be achieved as a condition of the exercise of such Appreciation
Rights.

 

(h) Successive
grants may be made to the same Participant regardless of whether any Appreciation Rights previously granted to the Participant remain
unexercised.

 

(i) No Appreciation
Right granted under the Plan may be exercised more than 10 years from the Date of Grant.

 

(j) No grant
of Appreciation Rights may provide for dividends, dividend equivalents or other similar distributions to be paid on such Appreciation
Rights.

 

(k) No Appreciation
Right shall include terms entitling the Participant to a grant of Option Rights or Appreciation Rights on exercise of the Appreciation
Right.

 

6. Restricted
Stock. The Board may, from time to time, authorize the granting of Restricted Stock to Participants upon such terms and conditions
consistent with the following provisions as it may determine:

 

 

    	 	7	 

     

    

 

		 	

	 	 	 

 

 

(a) Each
such grant will constitute an immediate transfer of the ownership of Shares to the Participant in consideration of the performance of
services, entitling such Participant to voting, dividend and other ownership rights, but such rights shall be subject to such restrictions
and the fulfillment of such conditions (which may include the achievement of Management Objectives) during the Restriction Period as
the Board may determine.

 

(b) Each
such grant may be made without additional consideration or in consideration of a payment by such Participant that is less than the Market
Value Per Share at the Date of Grant.

 

(c) Each
such grant will provide that the Restricted Stock covered by such grant that vests upon the passage of time will be subject to a “substantial
risk of forfeiture” within the meaning of Section 83 of the Code for a Restriction Period to be determined by the Board at the
Date of Grant or upon achievement of Management Objectives referred to in subparagraph (e) below.

 

(d) Each
such grant will provide that during, and may provide that after, the Restriction Period, the transferability of the Restricted Stock
will be prohibited or restricted in the manner and to the extent prescribed by the Board at the Date of Grant (which restrictions may
include, without limitation, rights of repurchase or first refusal in Inseego or provisions subjecting the Restricted Stock to a continuing
substantial risk of forfeiture in the hands of any transferee).

 

(e) Any
grant of Restricted Stock may specify Management Objectives that, if achieved, will result in termination or early termination of the
restrictions applicable to such Restricted Stock.

 

(f) Notwithstanding
anything to the contrary contained in the Plan, any grant of Restricted Stock may provide for the earlier termination of restrictions
on such Restricted Stock in the event of the retirement, death or disability, or other termination of employment of a Participant, or
a Change in Control.

 

(g) Any
such grant of Restricted Stock may require that any or all dividends or other distributions paid thereon during the Restriction Period
be automatically deferred and reinvested in additional shares of Restricted Stock or paid in cash, which may be subject to the same restrictions
as the underlying Award; provided, however, that dividends or other distributions on Restricted Stock subject to Management Objectives
shall be deferred and paid in cash upon the achievement of the applicable Management Objectives and the lapse of all restrictions on
such Restricted Stock.

 

(h) Unless
otherwise directed by the Board, (i) all certificates representing shares of Restricted Stock will be held in custody by Inseego until
all restrictions thereon will have lapsed, together with a stock power or powers executed by the Participant in whose name such certificates
are registered, endorsed in blank and covering such Shares, or (ii) all shares of Restricted Stock will be held at Inseego’s transfer
agent in book entry form with appropriate restrictions relating to the transfer of such shares of Restricted Stock.

 

7. Restricted
Stock Units. The Board may, from time to time, authorize the granting of Restricted Stock Units to Participants upon such terms and
conditions consistent with the following provisions as it may determine:

 

(a) Each
such grant will constitute the agreement by Inseego to deliver Shares or cash to the Participant in the future in consideration of the
performance of services, but subject to such restrictions and the fulfillment of such conditions (which may include the achievement of
Management Objectives) during the Restriction Period as the Board may specify.

 

(b) Each
such grant may be made without additional consideration or in consideration of a payment by such Participant that is less than the Market
Value Per Share at the Date of Grant.

 

 

    	 	8	 

     

    

 

		 	

	 	 	 

 

 

(c) Notwithstanding
anything to the contrary contained in the Plan, any grant of Restricted Stock Units may provide for the earlier lapse or modification
of the Restriction Period in the event of the retirement, death or disability, or other termination of employment of a Participant, or
a Change in Control.

 

(d) During
the Restriction Period, the Participant will have no right to transfer any rights under his or her Award and will have no rights of ownership
in the Restricted Stock Units and will have no right to vote them, but the Board may at the Date of Grant, authorize the payment of dividend
equivalents on such Restricted Stock Units on either a current, deferred or contingent basis either in cash, additional Restricted Stock
Units or in additional Shares; provided, however, that dividend equivalents on Restricted Stock Units subject to Management Objectives
shall be deferred and paid in cash upon the achievement of the applicable Management Objectives and the lapse of all restrictions on
such Restricted Stock Units.

 

(e) Each
grant of Restricted Stock Units will specify the time and manner of payment of the Restricted Stock Units that have been earned.

 

8. Annual
Incentive Awards, Performance Shares and Performance Units. The Board may, from time to time, authorize the granting of Annual Incentive
Awards, Performance Shares and Performance Units that will become payable to a Participant upon achievement of specified Management Objectives
during the Performance Period, upon such terms and conditions consistent with the following provisions as it may determine:

 

(a) Each
grant will specify either the number of shares, or amount of cash, payable with respect to Annual Incentive Awards, Performance Shares
or Performance Units to which it pertains, which number or amount payable may be subject to adjustment to reflect changes in compensation
or other factors.

 

(b) The
Performance Period with respect to each Annual Incentive Award, Performance Share or Performance Unit will be such period of time (not
less than one year in the case of each Performance Share and Performance Unit), as will be determined by the Board at the time of grant,
which Performance Period may be subject to earlier lapse or other modification in the event of the retirement, death or disability, or
other termination of employment of a Participant, or a Change in Control.

 

(c) Any
grant of Annual Incentive Awards, Performance Shares or Performance Units will specify Management Objectives that, if achieved, will
result in payment or early payment of the Award and may set forth a formula for determining the number of Shares, or amount of cash,
payable with respect to Annual Incentive Awards, Performance Shares or Performance Units that will be earned if performance is at or
above the minimum or threshold level or levels.

 

(d) Each
grant will specify the time and manner of payment of Annual Incentive Awards, Performance Shares or Performance Units that have been
earned. Any grant of Performance Shares or Performance Units may specify that the amount payable with respect thereto may be paid by
Inseego in cash, in Shares or in any combination thereof and will retain in the Board the right to elect among those alternatives.

 

(e) Any
grant of Annual Incentive Awards, Performance Shares or Performance Units may specify that the amount payable or the number of Shares
issued with respect thereto may not exceed maximums specified by the Board at the Date of Grant.

 

(f) The
Board may at the Date of Grant of Performance Shares provide for the payment of dividend equivalents to the holder thereof on either
a current, deferred or contingent basis, either in cash or in additional Shares; provided, however, that dividend equivalents on Performance
Shares shall be deferred and paid in cash upon the achievement of the applicable Management Objectives.

 

 

    	 	9	 

     

    

 

		 	

	 	 	 

 

 

9. Other
Awards.

 

(a) The
Board may, subject to limitations under applicable law, grant to any Participant such Other Awards that may be denominated or payable
in, valued in whole or in part by reference to, or otherwise based on, or related to, Shares or factors that may influence the value
of such Shares, including, without limitation, awards consisting of securities or other rights convertible or exchangeable into Shares,
purchase rights for Shares, awards with value and payment contingent upon performance of the Company or specified Subsidiaries, Affiliates
or other business units thereof or any other factors designated by the Board, and awards valued by reference to the book value of Shares
or the value of securities of, or the performance of specified Subsidiaries or Affiliates or other business units of Inseego. The Board
shall determine the terms and conditions of such awards. Shares delivered pursuant to an Award in the nature of a purchase right granted
under this Section 9 shall be purchased for such consideration, paid for at such time, by such methods, and in such forms, including,
without limitation, cash, Shares, Other Awards, notes or other property, as the Board shall determine.

 

(b) Except
as otherwise provided in Section 15(b), cash Awards, as independent Awards or as an element of or supplement to any other Award granted
under the Plan, may also be granted pursuant to this Section 9.

 

(c) The
Board may grant Shares as a bonus, or may grant other Awards in lieu of obligations of Inseego or a Subsidiary to pay cash or deliver
other property under the Plan or under other plans or compensatory arrangements, subject to such terms as shall be determined by the
Board in a manner that complies with Section 409A of the Code.

 

10. Transferability.

 

(a) Except
as otherwise determined by the Board, no Awards granted under the Plan and no rights under any such Awards shall be assignable, alienable,
saleable, or transferable by the Participant except by will or the laws of descent and distribution, and in no event shall any such Award
granted under the Plan be transferred for value. Except as otherwise determined by the Board, Option Rights and Appreciation Rights will
be exercisable during the Participant’s lifetime only by him or her or, in the event of the Participant’s legal incapacity
to do so, by his or her guardian or legal representative acting on behalf of the Participant in a fiduciary capacity under state law
and/or court supervision.

 

(b) The
Board may specify at the Date of Grant that part or all of the Shares that are to be issued by the Company upon the exercise of Option
Rights or Appreciation Rights, upon the termination of the Restriction Period applicable to Restricted Stock or Restricted Stock Units
or upon payment under any grant of Performance Shares, Performance Units or Other Awards will be subject to further restrictions on transfer.

 

11. Adjustments.
The Board shall make or provide for such adjustments in the number of Shares covered by outstanding Option Rights, Appreciation Rights,
Restricted Stock, Restricted Stock Units, Performance Shares and Performance Units granted hereunder and, if applicable, in the number
of Shares covered by Other Awards, in the Option Price and Base Price provided in outstanding Option Rights or Appreciation Rights, and
in the kind of Shares covered thereby, as the Board, in its sole discretion, may determine is equitably required to prevent dilution
or enlargement of the rights of Participants that otherwise would result from (a) any stock dividend, stock split, combination of shares,
recapitalization or other change in the capital structure of the Company, (b) any merger, consolidation, spin-off, split-off, spin-out,
split-up, reorganization, partial or complete liquidation or other distribution of assets, issuance of rights or warrants to purchase
securities, or (c) any other corporate transaction or event having an effect similar to any of the foregoing. Moreover, in the event
of any such transaction or event or in the event of a Change in Control, the Board, in its discretion, may provide in substitution for
any or all outstanding Awards under the Plan such alternative consideration (including cash), if any, as it may determine to be equitable
in the circumstances and may require in connection therewith the surrender of all Awards so replaced in a manner that complies with Section
409A of the Code. In addition, for each Option Right or Appreciation Right with an Option Price or Base Price greater than the consideration
offered in connection with any such transaction or event or Change in Control, the Board may in its sole discretion elect to cancel such
Option Right or Appreciation Right without any payment to the person holding such Option Right or Appreciation Right. The Board shall
also make or provide for such adjustments in the number of Shares specified in Section 3 of the Plan as the Board in its sole discretion,
may determine is appropriate to reflect any transaction or event described in this Section 11; provided, however, that any such adjustment
to the number specified in Section 3(a)(iii) will be made only if and to the extent that such adjustment would not cause any Option Right
intended to qualify as an Incentive Stock Option to fail so to qualify.

 

 

    	 	10	 

     

    

 

		 	

	 	 	 

 

 

12. Administration
of the Plan.

 

(a) The
Plan will be administered by the Board, which may from time to time delegate all or any part of its authority under the Plan to the Committee.
To the extent of any such delegation, references in the Plan to the Board will be deemed to be references to such Committee. A majority
of the Committee will constitute a quorum, and the action of the members of the Committee present at any meeting at which a quorum is
present, or acts unanimously approved in writing, will be the acts of the Committee.

 

(b) To the
extent permitted by applicable law, including any rule of the Nasdaq Stock Market, the Board or Committee may delegate its duties under
the Plan to a Secondary Committee, subject to such conditions and limitations as the Board or Committee shall prescribe; provided, however,
that: (i) only the Board or Committee may grant an Award to a Participant who is subject to Section 16 of the Exchange Act; and (ii)
the Secondary Committee shall report periodically to the Board or the Committee, as the case may be, regarding the nature and scope of
the Awards granted pursuant to the authority delegated. To the extent of any such delegation, references or deemed references in the
Plan to the Committee will be deemed to be references to such Secondary Committee. A majority of the Secondary Committee will constitute
a quorum, and the action of the members of the Secondary Committee present at any meeting at which a quorum is present, or acts unanimously
approved in writing, will be the acts of the Secondary Committee.

 

(c) The
Board shall have full and exclusive discretionary power to interpret the terms and the intent of this Plan and any Evidence of Award
or other agreement or document ancillary to or in connection with this Plan, to determine eligibility for Awards and to adopt such rules,
regulations, forms, instruments, and guidelines for administering this Plan as the Board may deem necessary or proper. Such authority
shall include, but not be limited to, selecting Award recipients, establishing all Award terms and conditions, including the terms and
conditions set forth in an Evidence of Award, granting Awards as an alternative to or as the form of payment for grants or rights earned
or due under compensation plans or arrangements of the Company, construing any ambiguous provision of the Plan or any Evidence of Award,
and, subject to Sections 15 and 18, adopting modifications and amendments to this Plan or any Evidence of Award, including without limitation,
any that are necessary to comply with the laws of the countries and other jurisdictions in which Inseego, its Affiliates, and/or its
Subsidiaries operate. The grant of any Award that specifies Management Objectives that must be achieved before such Award can be earned
or paid will specify that, before such Award will be earned and paid, the Board must certify that the Management Objectives have been
satisfied.

 

(d) The
interpretation and construction by the Board of any provision of this Plan or of any Evidence of Award or other agreement or document
ancillary to or in connection with this Plan and any determination by the Board pursuant to any provision of the Plan or of any such
Evidence of Award or other agreement or document ancillary to or in connection with this Plan will be final and conclusive. No member
of the Board will be liable for any such action or determination made in good faith.

 

(e) Any
Participant who believes he or she is being denied any benefit or right under the Plan or under any Award or Evidence of Award may file
a written claim with the Committee. Any claim must be delivered to the Committee within six month of the specific event giving rise to
the claim. Untimely claims will not be processed and shall be deemed denied. The Committee, or its designee, generally will notify the
Participant of its decision in writing as soon as administratively practicable. Claims shall be deemed denied if the Committee does not
respond in writing within 180 days of the date the written claim is delivered to the Committee. The Committee’s decision is final
and conclusive and binding on all Persons. No lawsuit or arbitration relating to the Plan may be filed or commenced before a written
claim is filed with the Committee and is denied or deemed denied, and any lawsuit must be filed within one year of such denial or deemed
denial or be forever barred.

 

13. Non
U.S. Participants. In order to facilitate the making of any grant or combination of grants under the Plan, the Board may provide
for such special terms for Awards to Participants who are foreign nationals or who are employed by Inseego or any Subsidiary outside
of the United States of America, as the Board may consider necessary or appropriate to accommodate differences in local law, tax policy
or custom. Moreover, the Board may approve such supplements to or amendments, restatements or alternative versions of the Plan (including
without limitation, sub-plans) as it may consider necessary or appropriate for such purposes, without thereby affecting the terms of
the Plan as in effect for any other purpose, and the Secretary or other appropriate officer of Inseego may certify any such document
as having been approved and adopted in the same manner as the Plan. No such special terms, supplements, amendments or restatements, however,
will include any provisions that are inconsistent with the terms of the Plan as then in effect unless the Plan could have been amended
to eliminate such inconsistency without further approval by the stockholders of Inseego.

 

 

    	 	11	 

     

    

 

		 	

	 	 	 

 

 

14. Withholding
Taxes. To the extent that the Company is required to withhold federal, state, local or foreign taxes in connection with any payment
made or benefit realized by a Participant or other Person under the Plan, and the amounts available to the Company for such withholding
are insufficient, it will be a condition to the receipt of such payment or the realization of such benefit that the Participant or such
other Person make arrangements satisfactory to the Company for payment of the balance of such taxes required to be withheld, which arrangements
(in the discretion of the Board) may include relinquishment of a portion of such benefit. If a Participant’s benefit is to be received
in the form of Shares, and such Participant fails to make arrangements for the payment of tax, the Company shall withhold such Shares
having a value that shall not exceed the statutory maximum amount permitted to be withheld. Notwithstanding the foregoing, when a Participant
is required to pay the Company an amount required to be withheld under applicable income and employment tax laws, the Participant may
elect, or the Company may require the Participant, to satisfy the obligation, in whole or in part, by electing to have withheld, from
the Shares required to be delivered to the Participant, Shares having a value equal to the amount required to be withheld, or by delivering
to the Company other Shares held by such Participant. The Shares used for tax withholding will be valued at an amount equal to the Market
Value Per Share of such Shares on the date the benefit is to be included in Participant’s income. Participants shall also make
such arrangements as the Company may require for the payment of any withholding tax obligation that may arise in connection with the
disposition of Shares acquired upon the exercise of Option Rights.

 

15. Amendments,
Etc.

 

(a) The
Board may at any time and from time to time amend the Plan in whole or in part; provided, however, that if an amendment to the Plan must
be approved by the stockholders of Inseego in order to comply with applicable law or the rules of the Nasdaq Stock Market or, if the
Shares are not traded on the Nasdaq Stock Market, the principal national securities exchange upon which the Shares are traded or quoted,
then, such amendment will be subject to stockholder approval and will not be effective unless and until such approval has been obtained.

 

(b) Except
in connection with a corporate transaction or event described in Section 11 of the Plan, the terms of outstanding Awards may not be amended
to reduce the Option Price of outstanding Option Rights or the Base Price of outstanding Appreciation Rights, and no outstanding Option
Rights or Appreciation Rights may be cancelled in exchange for other Awards, or cancelled in exchange for Option Rights or Appreciation
Rights with an Option Price or Base Price, as applicable, that is less than the Option Price of the original Option Rights or Base Price
of the original Appreciation Rights, as applicable, or cancelled in exchange for cash, without stockholder approval. This Section 15(b)
is intended to prohibit (without stockholder approval) the repricing of “underwater” Option Rights and Appreciation Rights
and will not be construed to prohibit the adjustments provided for in Section 11 of the Plan. Notwithstanding any provision of the Plan
to the contrary, this Section 15(b) may not be amended without approval by Inseego’s stockholders.

 

(c) If permitted
by Section 409A of the Code, in case of termination of employment by reason of death, disability or normal or early retirement, or in
the case of unforeseeable emergency or other special circumstances, of a Participant who holds an Option Right or Appreciation Right
not immediately exercisable in full, or any Restricted Stock or any Restricted Stock Units as to which the Restriction Period has not
been completed, or any Annual Incentive Awards, Performance Shares or Performance Units which have not been fully earned, or any Other
Awards subject to any vesting schedule or transfer restriction, or who holds Shares subject to any transfer restriction imposed pursuant
to Section 10(b) of the Plan, the Board may, in its sole discretion, accelerate the time at which such Option Right, Appreciation Right
or Other Award may be exercised or the time when such Restriction Period will end or the time at which such Annual Incentive Awards,
Performance Shares or Performance Units will be deemed to have been fully earned or the time when such transfer restriction will terminate
or may waive any other limitation or requirement under any such Award.

 

(d) Subject
to Section 16(d) of the Plan, the Board may amend the terms of any Award theretofore granted under the Plan prospectively or retroactively,
but subject to Section 11 of the Plan, no such amendment shall impair the rights of any Participant without his or her consent, except
as necessary to comply with changes in law or accounting rules applicable to Inseego. The Board may, in its discretion, terminate the
Plan at any time.

 

Termination
of the Plan will not affect the rights of Participants or their successors under any Awards outstanding hereunder on the date of termination.

 

 

    	 	12	 

     

    

 

		 	

	 	 	 

 

 

16. Compliance
with the Code.

 

(a) To the
extent applicable, it is intended that the Plan and any grants made hereunder comply with the provisions of Section 409A of the Code,
so that the income inclusion provisions of Section 409A of the Code do not apply to the Participants. The Plan and any grants made hereunder
shall be administered in a manner consistent with this intent. Any reference in the Plan to Section 409A of the Code will also include
any regulations or any other formal guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal
Revenue Service.

 

(b) Neither
a Participant nor any of a Participant’s creditors or beneficiaries shall have the right to subject any deferred compensation (within
the meaning of Section 409A of the Code) payable under the Plan and grants hereunder to any anticipation, alienation, sale, transfer,
assignment, pledge, encumbrance, attachment or garnishment. Except as permitted under Section 409A of the Code, any deferred compensation
(within the meaning of Section 409A of the Code) payable to a Participant or for a Participant’s benefit under the Plan and grants
hereunder may not be reduced by, or offset against, any amount owing by a Participant to the Company or any of its Affiliates.

 

(c) If,
at the time of a Participant’s separation from service (within the meaning of Section 409A of the Code), (i) the Participant shall
be a specified employee (within the meaning of Section 409A of the Code and using the identification methodology selected by Inseego
from time to time) and (ii) Inseego shall make a good faith determination that an amount payable hereunder constitutes deferred compensation
(within the meaning of Section 409A of the Code) the payment of which is required to be delayed pursuant to the six-month delay rule
set forth in Section 409A of the Code in order to avoid taxes or penalties under Section 409A of the Code, then Inseego shall not pay
such amount on the otherwise scheduled payment date but shall instead pay it, without interest, on the tenth business day of the month
after such six-month period.

 

(d) Notwithstanding
any provision of the Plan and grants hereunder to the contrary, in light of the uncertainty with respect to the proper application of
the Code, Inseego reserves the right to make amendments to the Plan and grants hereunder as Inseego deems necessary or desirable to avoid
the imposition of taxes or penalties under Section 409A of the Code, or adverse tax consequences under another Code provision, without
Participant consent. In any case, a Participant shall be solely responsible and liable for the satisfaction of all taxes and penalties
that may be imposed on a Participant or for a Participant’s account in connection with the Plan and grants hereunder (including
any taxes, penalties, and interest under Section 409A of the Code or another Code provision), and neither the Company nor any of
its Affiliates shall have any obligation to indemnify or otherwise hold a Participant nor anyone other than a Participant, including
a Participant’s estate or beneficiaries, harmless from any or all of such taxes or penalties.

 

17. Governing
Law. The Plan and all grants and Awards and actions taken thereunder shall be governed by and construed in accordance with the internal
substantive laws of the State of Delaware, without regard to principles of conflicts of laws.

 

18. Effective
Date/Termination. The Plan originally became effective as of June 18, 2009. This amendment and restatement was adopted by the Board
on May 11, 2018 and became effective on July 13, 2018. No grant will be made under the Plan more than 10 years after May 11, 2018,
but all grants made on or prior to such date will continue in effect thereafter subject to the terms of the Evidence of Award conveying
such grants and of the Plan.

 

19. Miscellaneous.

 

(a) Each
grant of an Award will be evidenced by an Evidence of Award and will contain such terms and provisions, consistent with the Plan, as
the Board may approve.

 

(b) Inseego
will not be required to issue any fractional Shares pursuant to the Plan. The Board may provide for the elimination of fractional Shares
or for the settlement of fractional Shares in cash.

 

 

    	 	13	 

     

    

 

		 	

	 	 	 

 

 

(c) The
Plan will not confer upon any Participant any right with respect to continuance of employment or other service with Inseego or any Subsidiary
or Affiliate, nor will it interfere in any way with any right Inseego or any Subsidiary or Affiliate would otherwise have to terminate
such Participant’s employment or other service at any time.

 

(d) No person
shall have any claim to be granted any Award under the Plan. Without limiting the generality of the foregoing, the fact that a target
Award is established for the job value or level for an Employee shall not entitle any Employee to an Award hereunder. Except as provided
specifically herein, a Participant or a transferee of an Award shall have no rights as a stockholder with respect to any Shares covered
by any Award until the date as of which he or she is actually recorded as the holder of such Shares upon the stock records of the Company.

 

(e) Determinations
by the Board or the Committee under the Plan relating to the form, amount and terms and conditions of grants and Awards need not be uniform,
and may be made selectively among persons who receive or are eligible to receive grants and Awards under the Plan, whether or not such
persons are similarly situated.

 

(f) To the
extent that any provision of the Plan would prevent any Option Right that was intended to qualify as an Incentive Stock Option from qualifying
as such, that provision will be null and void with respect to such Option Right. Such provision, however, will remain in effect for other
Option Rights and there will be no further effect on any provision of the Plan.

 

(g) No Award
under the Plan may be exercised by the holder thereof if such exercise, and the receipt of cash or stock thereunder, would be, in the
opinion of counsel selected by the Board, contrary to law or the regulations of any duly constituted authority having jurisdiction over
the Plan.

 

(h) Absence
or leave approved by a duly constituted officer of Inseego or any of its Subsidiaries shall not be considered interruption or termination
of service of any Employee for any purposes of the Plan or Awards granted hereunder.

 

(i) The
Board may condition the grant of any Award or combination of Awards authorized under the Plan on the surrender or deferral by the Participant
of his or her right to receive a cash bonus or other compensation otherwise payable by Inseego or a Subsidiary to the Participant.

 

(j) If any
provision of the Plan is or becomes invalid, illegal or unenforceable in any jurisdiction, or would disqualify the Plan or any Award
under any law deemed applicable by the Board, such provision shall be construed or deemed amended or limited in scope to conform to applicable
laws or, in the discretion of the Board, it shall be stricken and the remainder of the Plan shall remain in full force and effect.

 

(k) Any
Evidence of Award may: (i) provide for recoupment by the Company of all or any portion of an Award upon such terms and conditions as
the Board or Committee may specify in such Evidence of Award; or (ii) include restrictive covenants, including, without limitation, non-competition,
non-disparagement and confidentiality conditions or restrictions, that the Participant must comply with during employment by or service
to the Company and/or within a specified period after termination as a condition to the Participant’s receipt or retention of all
or any portion of an Award. This Section 19(k) shall not be the Company’s exclusive remedy with respect to such matters. This Section
19(k) shall not apply after a Change in Control, unless otherwise specifically provided in the Evidence of Award.

 

 

    	 	14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]